Rare diseases
Investigational molecules
Locations
Back to the Netherlands150 clinical trials in S-Hertogenbosch, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
The NetherlandsStudy of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer
The NetherlandsStudy comparing FOLFIRINOX versus gemcitabine-based chemoradiotherapy in patients with resectable or borderline resectable pancreatic cancer
The NetherlandsStudy on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment
The NetherlandsStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
The NetherlandsStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on acute myeloid leukemia and chronic lymphocytic leukemia, evaluating innovative combination therapies and treatment approaches. Studies also include investigations into advanced breast cancer treatments and novel therapies for small cell lung cancer.
Several trials are exploring targeted therapies and immunotherapy combinations to improve patient outcomes.
Research initiatives examining heart failure prevention and stroke management, including studies on new therapeutic combinations and preventive treatments for cardiovascular events.
Focus on developing innovative treatments to reduce cardiovascular mortality and improve patient outcomes.
Clinical investigations targeting Alzheimer's disease, evaluating new therapeutic approaches for both mild cognitive impairment and dementia. Studies aim to improve cognitive function and quality of life.
Trials explore novel drug combinations and treatment strategies for neurodegenerative conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
